BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 17, 2003
 |  BioCentury  |  Finance

CAT nipped

CAT nipped

Shareholders of Cambridge Antibody (LSE:CAT; CATG) last week voted in favor of the company's proposal to buy Oxford GlycoSciences(LSE:OGS; OGSI) in an all-share bid. But on Friday OGS withdrew its recommendation of CAT's offer. OGS said its board still was not recommending the higher counter bid made last month by Celltech(LSE:CCH; CLL), but noted that the difference in deal values caused the withdrawal of the CAT recommendation. Based on CAT's Friday close at 415p, OGS would be...

Read the full 370 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >